ID   HO8910-TAX/CBP
AC   CVCL_B0WD
DR   Wikidata; Q108820493
RX   PubMed=34535163;
CC   Problematic cell line: Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6868 ! HO-8910
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
RX   PubMed=34535163; DOI=10.1186/s13048-021-00873-2; PMCID=PMC8447655;
RA   Zhang, Jing
RA   Xie, Su-Hong
RA   Zhou, Lei
RA   Tang, Xiao-Yu
RA   Guan, Xiao-Lin
RA   Deng, Min-Jie
RA   Zheng, Hui
RA   Wang, Yan-Chun
RA   Lu, Ren-Quan
RA   Guo, Lin
RT   "Up-regulation of GSTT1 in serous ovarian cancer associated with
RT   resistance to TAXOL / carboplatin.";
RL   J. Ovarian Res. 14:122.1-122.14(2021).
//